- Home
- CGEM vs VLGEA Comparison
CGEM vs VLGEA Comparison
Compare CGEM & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- VLGEA
- Stock Information
- Founded
- CGEM 2016
- VLGEA 1937
- Country
- CGEM United States
- VLGEA United States
- Employees
- CGEM N/A
- VLGEA N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- VLGEA Food Chains
- Sector
- CGEM Health Care
- VLGEA Consumer Staples
- Exchange
- CGEM Nasdaq
- VLGEA Nasdaq
- Market Cap
- CGEM 530.0M
- VLGEA 541.1M
- IPO Year
- CGEM 2021
- VLGEA N/A
- Fundamental
- Price
- CGEM $7.50
- VLGEA $38.72
- Analyst Decision
- CGEM Strong Buy
- VLGEA
- Analyst Count
- CGEM 5
- VLGEA 0
- Target Price
- CGEM $30.00
- VLGEA N/A
- AVG Volume (30 Days)
- CGEM 371.7K
- VLGEA 57.0K
- Earning Date
- CGEM 08-07-2025
- VLGEA 06-03-2025
- Dividend Yield
- CGEM N/A
- VLGEA 2.60%
- EPS Growth
- CGEM N/A
- VLGEA 12.55
- EPS
- CGEM N/A
- VLGEA 3.80
- Revenue
- CGEM N/A
- VLGEA $2,299,253,000.00
- Revenue This Year
- CGEM N/A
- VLGEA N/A
- Revenue Next Year
- CGEM N/A
- VLGEA N/A
- P/E Ratio
- CGEM N/A
- VLGEA $10.15
- Revenue Growth
- CGEM N/A
- VLGEA 3.94
- 52 Week Low
- CGEM $6.85
- VLGEA $24.90
- 52 Week High
- CGEM $21.01
- VLGEA $40.15
- Technical
- Relative Strength Index (RSI)
- CGEM 41.43
- VLGEA 57.17
- Support Level
- CGEM $7.53
- VLGEA $36.86
- Resistance Level
- CGEM $9.25
- VLGEA $39.38
- Average True Range (ATR)
- CGEM 0.38
- VLGEA 0.87
- MACD
- CGEM -0.13
- VLGEA 0.07
- Stochastic Oscillator
- CGEM 13.02
- VLGEA 74.93
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.